Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE BARTHELEMY - RENOUF : revenue, balance sheet and financial ratios

PHARMACIE BARTHELEMY - RENOUF is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-SAUVEUR-LE-VICOMTE (50390), this company of category PME shows in 2024 a net income positive of 216 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE BARTHELEMY - RENOUF (SIREN 502107881)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 215 903 € 261 295 € 279 623 € 211 606 € 147 857 € 160 175 € 77 752 € 165 706 € 192 370 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE BARTHELEMY - RENOUF generates positive net income of 216 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 192 k€ -> 216 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

215 903 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 56%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

55.658%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

60.385%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

47.4%

Solvency indicators evolution
PHARMACIE BARTHELEMY - RENOUF

Sector positioning

Debt ratio
55.66 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good

In 2024, the debt ratio of PHARMACIE BARTHELEMY - RE... (55.66) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
60.38% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +9 pts over 3 years

In 2024, the financial autonomy of PHARMACIE BARTHELEMY - RE... (60.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 358.99. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

358.986

Liquidity indicators evolution
PHARMACIE BARTHELEMY - RENOUF

Sector positioning

Liquidity ratio
358.99 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent +7 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE BARTHELEMY - RE... (358.99) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE BARTHELEMY - RENOUF in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE BARTHELEMY - RENOUF is estimated at 3 014 165 € (range 2 099 017€ - 4 509 364€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2099k€ 3014k€ 4509k€
3 014 165 € Range: 2 099 017€ - 4 509 364€
NAF 5 année 2024

Valuation method used

Net Income Multiple
215 903 € × 14.0x = 3 014 165 €
Range: 2 099 017€ - 4 509 364€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE BARTHELEMY - RENOUF with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE BARTHELEMY - RENOUF

What is the revenue of PHARMACIE BARTHELEMY - RENOUF ?

The revenue of PHARMACIE BARTHELEMY - RENOUF is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE BARTHELEMY - RENOUF profitable?

Yes, PHARMACIE BARTHELEMY - RENOUF generated a net profit of 216 k€ in 2024.

Where is the headquarters of PHARMACIE BARTHELEMY - RENOUF ?

The headquarters of PHARMACIE BARTHELEMY - RENOUF is located in SAINT-SAUVEUR-LE-VICOMTE (50390), in the department Manche.

Where to find the tax return of PHARMACIE BARTHELEMY - RENOUF ?

The tax return of PHARMACIE BARTHELEMY - RENOUF is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE BARTHELEMY - RENOUF operate?

PHARMACIE BARTHELEMY - RENOUF operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.